Hugh J. Field

6.6k total citations · 1 hit paper
133 papers, 4.9k citations indexed

About

Hugh J. Field is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Hugh J. Field has authored 133 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Epidemiology, 42 papers in Immunology and 28 papers in Genetics. Recurrent topics in Hugh J. Field's work include Herpesvirus Infections and Treatments (111 papers), Cytomegalovirus and herpesvirus research (48 papers) and Virus-based gene therapy research (28 papers). Hugh J. Field is often cited by papers focused on Herpesvirus Infections and Treatments (111 papers), Cytomegalovirus and herpesvirus research (48 papers) and Virus-based gene therapy research (28 papers). Hugh J. Field collaborates with scholars based in United Kingdom, United States and Australia. Hugh J. Field's co-authors include P. Wildy, T. J. Hill, G. Darby, Erik De Clercq, Alana M. Thackray, Josh Slater, Subhajit Biswas, W. A. Blyth, Aftab Awan and John S. Gibson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Hugh J. Field

131 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice

1979 153 citations Hugh J. Field et al. profile →

Peers

Countries citing papers authored by Hugh J. Field

Since Specialization

Citations

This map shows the geographic impact of Hugh J. Field's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh J. Field with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh J. Field more than expected).

Fields of papers citing papers by Hugh J. Field

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh J. Field. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh J. Field. The network helps show where Hugh J. Field may publish in the future.

Co-authorship network of co-authors of Hugh J. Field

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh J. Field. A scholar is included among the top collaborators of Hugh J. Field based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh J. Field. Hugh J. Field is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiviral drug resistance and helicase–primase inhibitors of herpes simplex virus 2010 ·Drug Resistance Updates ·Hugh J. Field, Subhajit Biswas	40
2	Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds 2008 ·Journal of Virological Methods ·Islam T. M. Hussein, Hugh J. Field	22
3	Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase–primase inhibitors, variously affect virus growth rate and pathogenicity 2008 ·Antiviral Research ·Subhajit Biswas, Laurence Tiley, Holger Zimmermann, Alexander Birkmann, Hugh J. Field	23
4	Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy 2005 ·British Journal of Pharmacology ·Erik De Clercq, Hugh J. Field	258
5	Protection of Specific-pathogen-free (Spf) Foals from Severe Equine Herpesvirus Type-1 (Ehv-1) Infection Following Immunization with Non-infectious L-particles 2002 ·The Journal of Microbiology ·Mohd Azmi Mohd Lila, (unknown), Frazer J. Rixon, John McLauchlan, Hugh J. Field	6
6	Protective Immune Reponses Induced by Non-infectious L-particles of Equine Herpesvirus Type-1 2002 ·The Journal of Microbiology ·Mohd Azmi Mohd Lila, Hugh J. Field, Frazer J. Rixon, John McLauchlan	4
7	Herpes simplex virus antiviral drug resistance — current trends and future prospects 2001 ·Journal of Clinical Virology ·Hugh J. Field	85
8	Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease 1998 ·Antiviral Research ·Aftab Awan, Johan Harmenberg, (unknown), Hugh J. Field	10
9	An Equine Herpesvirus-1 Gene 71 Deletant Is Attenuated and Elicits a Protective Immune Response in Mice 1997 ·Virology ·Ker R. Marshall, Yi Sun, Stuart M. Brown, Hugh J. Field	26
10	Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells 1993 ·Journal of General Virology ·Mohd Azmi Mohd Lila, Hugh J. Field	23
11	The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle 1993 ·Antiviral Research ·(unknown), Hugh J. Field	15
12	Pathogenicity of a Thymidine Kinase-Deficient Mutant of Equine Herpesvirus 1 in Mice and Specific Pathogen-Free Foals 1993 ·Journal of General Virology ·Josh Slater, John S. Gibson, Hugh J. Field	49
13	Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation 1992 ·Archives of Virology ·John S. Gibson, Josh Slater, Aftab Awan, Hugh J. Field	78
14	The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals 1992 ·Virology ·John S. Gibson, Josh Slater, Hugh J. Field	25
15	A murine model for studying EHV-1-induced abortion 1991 ·Research in Veterinary Science ·Aftab Awan, John S. Gibson, Hugh J. Field	43
16	Isolation of equine herpesvirus-1 mutants in the presence of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine: demonstration of resistance in vitro and in vivo 1991 ·Antiviral Research ·Hugh J. Field, Aftab Awan, Ricardo de la Fuente	7
17	A reliable method for establishing viral infection in the rabbit by intranasal inoculation 1990 ·Journal of Virological Methods ·(unknown), Hugh J. Field	9
18	Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity 1990 ·Protein Engineering Design and Selection ·Hugh J. Field, Geoffrey Yarranton, Anthony R. Rees	31
19	Persistent herpes simplex virus infection and mechanisms of virus drug resistance 1989 ·European Journal of Clinical Microbiology & Infectious Diseases ·Hugh J. Field	25
20	Genomic localization and sequence analysis of the putative bovine herpesvirus-1 DNA polymerase gene 1988 ·Archives of Virology ·(unknown), Hugh J. Field	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact